Earnings Per Share, Diluted of INTERPACE BIOSCIENCES, INC. from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
INTERPACE BIOSCIENCES, INC. quarterly and annual Earnings Per Share, Diluted in USD/shares history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • INTERPACE BIOSCIENCES, INC. Earnings Per Share, Diluted for the quarter ending 30 Sep 2025 was 0.03, a 92% decline year-over-year.
  • INTERPACE BIOSCIENCES, INC. Earnings Per Share, Diluted for the twelve months ending 30 Sep 2025 was 0, a 156% decline year-over-year.
  • INTERPACE BIOSCIENCES, INC. annual Earnings Per Share, Diluted for 2024 was 0.4, a 11% decline from 2023.
  • INTERPACE BIOSCIENCES, INC. annual Earnings Per Share, Diluted for 2023 was 0.45.
Source SEC data
View on sec.gov
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Change (%)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Change (%)

INTERPACE BIOSCIENCES, INC. Quarterly Earnings Per Share, Diluted (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 0 0.03 -0.35 -92% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 0 -0.14 -0.69 -125% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 0 0.06 -0.1 -62% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 0 -0.69 -0.93 -388% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 1 0.38 +0.42 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 0 0.55 +0.42 +323% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 0 0.16 +0.04 +33% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 0 0.24 +0.61 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 0 -0.04 +3.31 +99% 01 Jul 2023 30 Sep 2023 10-K 31 Mar 2025 2024 FY
Q2 2023 -3 0.13 +1.06 01 Apr 2023 30 Jun 2023 10-K 31 Mar 2025 2024 FY
Q1 2023 -4 0.12 +0.65 01 Jan 2023 31 Mar 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 -5 -0.37 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 -3.35 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 -0.93 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 -0.53 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q3 2018 -0.11 +0.04 +27% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 -0.07 +0.58 +89% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 -0.11 -0.66 -120% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q3 2017 -0.15 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3
Q2 2017 -0.65 +0.64 +50% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2018 Q2
Q1 2017 0.55 +3.24 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q2 2016 -1.29 01 Apr 2016 30 Jun 2016 10-Q 10 Aug 2017 2017 Q2
Q1 2016 -2.69 01 Jan 2016 31 Mar 2016 10-Q 12 May 2017 2017 Q1
Q3 2014 -0.29 -0.14 -93% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2014 2014 Q3
Q2 2014 -0.18 -0.12 -200% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 -0.11 -0.25 -179% 01 Jan 2014 31 Mar 2014 10-Q 19 Aug 2014 2014 Q1
Q3 2013 -0.15 01 Jul 2013 30 Sep 2013 10-Q 05 Nov 2014 2014 Q3
Q2 2013 -0.06 -0.03 -100% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014 2014 Q2
Q1 2013 0.14 +0.16 01 Jan 2013 31 Mar 2013 10-Q 19 Aug 2014 2014 Q1
Q2 2012 -0.03 +0.03 +50% 01 Apr 2012 30 Jun 2012 10-Q 05 Aug 2013 2013 Q2
Q1 2012 -0.02 01 Jan 2012 31 Mar 2012 10-Q 14 May 2013 2013 Q1
Q3 2011 -0.01 +0.1 +91% 01 Jul 2011 30 Sep 2011 10-Q 10 Nov 2011 2011 Q3
Q2 2011 -0.06 0 0% 01 Apr 2011 30 Jun 2011 10-Q 10 Aug 2011 2011 Q2
Q3 2010 -0.11 01 Jul 2010 30 Sep 2010 10-Q 10 Nov 2011 2011 Q3
Q2 2010 -0.06 01 Apr 2010 30 Jun 2010 10-Q 10 Aug 2011 2011 Q2

INTERPACE BIOSCIENCES, INC. Annual Earnings Per Share, Diluted (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 0.4 -0.05 -11% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 0.45 +5.63 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 -5.18 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.